NLRP3 and necrotizing enterocolitis: Therefore, taking into account the role that activated NLRP3 plays in NEC intestinal epithelial injury, the clinical application of NLRP3 inhibitors or the identification of new targets upstream of NLRP3 for early intervention may improve NEC prognosis.